Pulmonary arterial hypertension in connective tissue diseases

Allergology International

Volumn 60, Issue 4, 2011, Pages 405-409

  Yoshida, Shunji ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Connective tissue diseases; Corticosteroid; Doppler echocardiography; Mixed connective tissue disease; Pulmonary hypertension

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; ENDOTHELIN; IMMUNOSUPPRESSIVE AGENT; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; VASODILATOR AGENT;

ANEMIA; AORTA ARCH SYNDROME; CAUSE OF DEATH; CLINICAL FEATURE; COLD EXPOSURE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; FATIGUE; FEVER; FIBROSING ALVEOLITIS; FLUID INTAKE; HEART CATHETERIZATION; INFECTION; LUNG EMBOLISM; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY STENOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULITIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALT INTAKE; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION;

EID: 83455164856     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-RAI-0360     Document Type: Review

References (13)

1. Tojo T, Akiya K, Torikai K et al. [A nationwide epidemiological survey on the complication rate of pulmonary hypertension in patients with mixed connective tissue disease, systemic lupus erythematosus, systemic sclerosis and polymyositis/dermatomyositis]. In: [Annual Report of the Ministry of Health and Welfare, Mixed Connective Tissue Disease Research Committee]. 1999;3-6 (in Japanese).
2. Yoshida S, Fukaya S. [Analysis of frequency and pathology of pulmonary hypertension associated with connective tissue diseases]. In: [Annual Report of the Ministry of Health, Welfare and Labour, Systemic Autoimmune Diseases Research Committee]. 2004;40-3 (in Japanese).
3. Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of communitybased rheumatologists (the UNCOVER study). Arthritis Rheum 2005;52:2125-32.
4. Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
5. Yoshida S, Fukaya S. [Study on the pulmonary hypertension associated with mixed connective tissue disease]. In: [Annual Report of the Ministry of Health, Welfare, and Labour, Mixed Connective Tissue Disease Research Committee]. 2008;37-40 (in Japanese).
6. Torikai K, Fukaya S, Matsumoto Y et al. [Study on the prognosis of mixed connective tissue disease patients complicated with pulmonary hypertension]. In: [Annual Report of the Ministry of Health and Welfare, Mixed Connective Tissue Disease Research Committee]. 1999;20-3 (in Japanese).
7. Yoshida S, Fukaya S, Kyotani S et al. [Revision of the diagnostic criteria for mixed connective tissue disease associated pulmonary arterial hypertension]. In: [Annual Report of the Ministry of Health, Welfare and Labour, Mixed Connective Tissue Disease Research Committee]. 2011;7-13 (in Japanese).
8. Galie N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
9. Humbert M, Sitborn O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351: 1425-36.
10. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical Therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917-28.
11. Barst RJ, Gibbs JSR, Ghofrani HA et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J AmColl Cardiol 2009;54:S78-84.
12. Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 2006;130:182-9.
13. Yoshida S. [Therapeutic Guideline for MCTD-pulmonary hypertension-. Clinical Guidelines for Mixed Connective Tissue Disease (3rd edition)]. In: Mimori T (ed). [Ministry of Health, Welfare and Labour, Mixed Connective Tissue Disease Research Committee]. 2011;27-32 (in Japanese).